Roche Holding AG/Fr. ROG
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Roche Holding AG
Roche Holding AG is a global healthcare company based in Basel, Switzerland, operating primarily in the pharmaceuticals and diagnostics segments. The company develops and manufactures prescription drugs in various therapeutic areas, including oncology, immunology, infectious diseases, ophthalmology, and neuroscience. Roche's diagnostics division provides in vitro diagnostic tests and instruments for disease detection and management. Founded in 1896, Roche is known for its significant investments in research and development to advance personalized healthcare. It operates with a strong international presence, leveraging its strategic capabilities in biotechnology to maintain its competitive position in the healthcare industry.
Ticker
Fr. ROG
Sector
Primary listing
XSWX
Employees
103,249
Headquarters
Basel, Switzerland
Website
Roche Holding AG Metrics
BasicAdvanced
CHF 264B
20.47
CHF 16.04
0.20
CHF 9.70
2.95%
Price and volume
Market cap
CHF 264B
Beta
0.2
52-week high
CHF 374.90
52-week low
CHF 231.90
Average daily volume
1.2M
Dividend rate
CHF 9.70
Financial strength
Current ratio
1.383
Quick ratio
1.048
Long term debt to equity
75.697
Total debt to equity
87.637
Dividend payout ratio (TTM)
60.02%
Interest coverage (TTM)
17.66%
Profitability
EBITDA (TTM)
24,044
Gross margin (TTM)
74.49%
Net profit margin (TTM)
20.33%
Operating margin (TTM)
33.08%
Effective tax rate (TTM)
18.70%
Revenue per employee (TTM)
CHF 610,000
Management effectiveness
Return on assets (TTM)
12.94%
Return on equity (TTM)
37.27%
Valuation
Price to earnings (TTM)
20.468
Price to revenue (TTM)
4.125
Price to book
7.8
Price to tangible book (TTM)
37.73
Price to free cash flow (TTM)
19.987
Free cash flow yield (TTM)
5.00%
Free cash flow per share (TTM)
16.426
Dividend yield (TTM)
2.95%
Forward dividend yield
2.95%
Growth
Revenue change (TTM)
1.54%
Earnings per share change (TTM)
55.58%
3-year revenue growth (CAGR)
-1.26%
10-year revenue growth (CAGR)
2.31%
3-year earnings per share growth (CAGR)
1.43%
10-year earnings per share growth (CAGR)
4.55%
3-year dividend per share growth (CAGR)
1.04%
10-year dividend per share growth (CAGR)
1.92%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Roche Holding AG stock?
Roche Holding AG (ROG) has a market cap of Fr.264B as of March 12, 2026.
What is the P/E ratio for Roche Holding AG stock?
The price to earnings (P/E) ratio for Roche Holding AG (ROG) stock is 20.47 as of March 12, 2026.
Does Roche Holding AG stock pay dividends?
Yes, the Roche Holding AG (ROG) stock pays dividends to shareholders. As of March 12, 2026, the dividend rate is Fr.9.7 and the yield is 2.95%. Roche Holding AG has a payout ratio of 60.02% on a trailing twelve-month basis.
When is the next Roche Holding AG dividend payment date?
The next Roche Holding AG (ROG) dividend payment is scheduled for March 16, 2026.
What is the beta indicator for Roche Holding AG?
Roche Holding AG (ROG) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.